I am pleased to share with you the newest edition of industry insights with Heather Losey, Senior Director, Program Lead in Immuno-Oncology, Alkermes.

As one of the industries leading companies, Heather shares some exciting updates on Alkermes current pipeline programs and what she believes to be some of the industries biggest challenges.

Topics covered include: 

  • An insight into the ALKS 4230 Program and Alkermes Goals.

  • An overview and update of the ARTISTRY 1 & 2 studies. 

  • What are some of the industries biggest challenges that newcomers face?

Click to download your exclusive copy